Abstract
Introduction: Facial nerve hemangiomas are rare benign vascular tumors arising from the intratemporal facial nerve and represent a challenging disease due to their progressive effects on facial nerve function. Unlike many benign skull base tumors, these lesions may cause significant facial paralysis despite limited tumor size and minimal radiological progression. The optimal timing of surgical intervention remains controversial, particularly in patients with initially preserved facial nerve function, as early surgery may involve functional risks, whereas delayed intervention may result in irreversible nerve degeneration. Careful clinical follow-up, serial imaging, and timely decision-making are essential to optimize outcomes. Case Report: We present the microsurgical management of an intratemporal facial nerve hemangioma through a transmastoid approach combined with immediate hypoglossal-facial anastomosis for facial reanimation. A 41-year-old woman came with progressive facial weakness caused by a tumor involving the mastoid segment of the facial nerve. At initial evaluation, facial nerve function remained satisfactory; therefore, considering the benign nature of the lesion and preserved neurological function, a conservative strategy with serial magnetic resonance imaging follow-up was adopted. During a two-year follow-up period, the lesion remained radiographically stable, without significant evidence of tumor growth. However, despite imaging stability, the patient experienced progressive deterioration of facial nerve function, ultimately reaching House-Brackmann (HB) grade V facial paralysis. Considering the severe functional decline and the limited likelihood of spontaneous recovery, microsurgical treatment was indicated. A transmastoid approach was performed, providing adequate exposure of the mastoid segment of the facial nerve and allowing careful identification of the tumor and surrounding anatomical structures. Microsurgical dissection was performed under high magnification, with progressive removal of the vascular lesion and preservation of the surrounding neurovascular anatomy whenever possible. Due to extensive involvement of the facial nerve by the tumor, complete resection required sacrifice of the affected neural segment. To optimize facial rehabilitation and avoid prolonged denervation, an immediate end-to-end hypoglossal–facial anastomosis was performed during the same surgical procedure. Results: This reconstructive strategy provided a new motor source for facial musculature and aimed to maximize the potential for early functional recovery. Histopathological examination confirmed the diagnosis of facial nerve hemangioma. At the four-month postoperative follow-up, the patient demonstrated significant improvement in facial function, progressing from House–Brackmann grade V to House–Brackmann grade II. The patient achieved improved facial symmetry and motor recovery without reported significant hypoglossal nerve-related morbidity. Postoperative magnetic resonance imaging demonstrated gross-total tumor resection with no evidence of residual or recurrent disease. Conclusion: Facial nerve hemangiomas are uncommon lesions that may produce progressive and severe facial paralysis despite minimal or absent radiological growth. This case highlights the importance of considering functional deterioration, rather than imaging progression alone, when determining surgical timing. In patients presenting with advanced facial dysfunction, complete microsurgical resection through a transmastoid approach combined with immediate hypoglossal–facial anastomosis represents an effective treatment strategy. This approach allows definitive tumor removal while providing early facial reinnervation and favorable functional recovery.